原发性膜性肾病血栓栓塞临床预测模型的建立与验证
Establishment and Validation of a Predictive Model for Thromboembolism in Primary Membranous Nephropathy
摘要: 目的:建立原发性膜性肾病血栓栓塞预测模型并验证。方法:收集2018年8月1日~2020年12月31日于青岛大学附属医院测定抗磷脂酶A2受体抗体滴度的原发性膜性肾病病人119例,以D二聚体是否发生异常为分组依据分为血栓栓塞组(n = 39人),非血栓栓塞组(n = 80人)。利用差异性分析与单因素逻辑回归筛选患者合并血栓栓塞并发证的危险因素。根据多因素逻辑回归分析建立血栓栓塞并发症的临床预测模型,并对临床预测模型进行评价以及验证。结果:差异性分析后,血栓栓塞组与非血栓栓塞组患者在性别、血清白蛋白、血清PLA2R抗体、24小时尿蛋白定量这4项指标有显著性差异(P < 0.05)。在单因素逻辑回归分析中上述5项均有意义是血栓栓塞的危险因素(P < 0.05),其中经过多因素逻辑回归分析血清白蛋白与24小时尿蛋白定量可以认为是原发性膜性肾病血栓栓塞的独立危险因素(P < 0.05)。随后我们以这4项指标构建临床诊断模型并以列线图呈现。其有较好的评价性能。结论:基于性别、血清白蛋白、血清PLA2R抗体、24小时尿蛋白定量这4项指标,构建的原发性膜性肾病并发血栓栓塞的临床预测模型,对发生血栓栓塞并发症的区分度较高,有利于血栓栓塞并发症早期的防治。
Abstract: Objective: To establish and verify the prediction model of thromboembolism in primary membra-nous nephropathy. Methods: A total of 119 patients with primary membranous nephropathy, whose anti-phospholipase A2 receptor antibody titers were measured in The Affiliated Hospital of Qingdao University from August 1st, 2018 to December 31st, 2020, were divided into the thromboembolic group (n = 39) and the non-thromboembolic group (n = 80) according to the abnormality of D-dimer. Differential analysis and univariate logistic regression were used to screen the risk factors for patients with thromboembolism. The clinical prediction model of thromboembolic complications was established based on multivariate logistic regression analysis, and the clinical prediction model was evaluated and verified. Results: After difference analysis, there were significant differences in gender, serum albumin, serum PLA2R antibody and 24-hour urine protein quantification between thromboembolic group and non-thromboembolic group (P < 0.05). In univariate logistic regression analysis, all the above 4 items were significant risk factors for thromboembolism (P < 0.05), and serum albumin and 24-hour urine protein quantification could be considered as independent risk factors for thromboembolism of primary membranous nephropathy after multivariate logistic re-gression analysis (P < 0.05). Subsequently, we constructed a clinical diagnostic model based on these 4 indicators and presented it as a column chart. It has good evaluation performance. Conclu-sion: Based on the four indexes of gender, serum albumin, serum PLA2R antibody and 24-hour urine protein quantification, the clinical prediction model of primary membranous nephropathy complicated with thromboembolism was established, which has a high degree of differentiation in the occurrence of thromboembolism complications, and is conducive to the early prevention and treatment of thromboembolism complications.
文章引用:陈怿鹏, 何颖, 高鹏丽, 张嘉倩, 邢广群. 原发性膜性肾病血栓栓塞临床预测模型的建立与验证[J]. 临床医学进展, 2022, 12(7): 6621-6628. https://doi.org/10.12677/ACM.2022.127956

参考文献

[1] Mahalingasivam, V., Booth, J., Sheaff, M. and Yaqoob, M. (2018) Nephrotic Syndrome in Adults. Acute Medicine, 17, 36-43.
[2] Beck Jr., L.H., Bonegio, R.G., Lambeau, G., Beck, D.M., Powell, D.W., Cummins, T.D., Klein, J.B. and Salant, D.J. (2009) M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy. The New England Journal of Medicine, 361, 11-21. [Google Scholar] [CrossRef
[3] Beck Jr., L.H. and Salant, D.J. (2010) Membranous Nephropathy: Recent Travels and New Roads ahead. Kidney International, 77, 765-770. [Google Scholar] [CrossRef] [PubMed]
[4] Ronco, P. and Debiec, H. (2005) Molecular Pathomechanisms of Membranous Nephropathy: From Heymann Nephritis to Alloimmunization. Journal of the American Society of Neph-rology, 16, 1205-1213. [Google Scholar] [CrossRef
[5] Dai, H., Zhang, H. and He, Y. (2015) Diagnostic Accuracy of PLA2R Autoantibodies and Glomerular Staining for the Differentiation of Idiopathic and Secondary Membranous Nephropathy: An Updated Meta-Analysis. Scientific Reports, 5, Article No. 8803. [Google Scholar] [CrossRef] [PubMed]
[6] Harza, M., Ismail, G., Mitroi, G., Gherghiceanu, M., Preda, A., Mircescu, G. and Sinescu, I. (2013) Histological Diagnosis and Risk of Renal Vein Thrombosis, and Other Thrombotic Complica-tions in Primitive Nephrotic Syndrome. Romanian Journal of Morphology and Embryology, 54, 555-560.
[7] Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group (2021) KDIGO 2021 Clinical Practice Guide-line for the Management of Glomerular Diseases. Kidney International, 100, S1-S276.
[8] Pang, L., Zhang, A.M., Li, H.X., Du, J.L., Jiao, L.L., Duan, N., Liu, Y. and Yu, D. (2017) Serum anti-PLA2R Antibody and Glomerular PLA2R Deposition in Chinese Patients with Membranous Nephropathy: A Cross-Sectional Study. Medicine, 96, e7218. [Google Scholar] [CrossRef
[9] Qin, W., Beck Jr., L.H., Zeng, C., Chen, Z., Li, S., Zuo, K., Salant, D.J. and Liu, Z. (2011) Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy. Journal of the American Society of Nephrology, 22, 1137-1143. [Google Scholar] [CrossRef
[10] Dou, Y., Zhang, L., Liu, D., Wang, C., Quan, S., Ma, S., Xiao, J., Cheng, G., Liu, Z. and Zhao, Z. (2016) The Accuracy of the Anti-Phospholipase A2 Receptor Antibody in the Diagnosis of Idiopathic Membranous Nephropathy: A Comparison of Different Cutoff Values as Measured by the ELISA Method. International Urology and Nephrology, 48, 845-849. [Google Scholar] [CrossRef] [PubMed]
[11] Senior, K., Burles, K., Wang, D., Grigat, D., Innes, G.D., Andruchow, J.E., Lang, E.S. and McRae, A.D. (2018) Age- Adjusted D-Dimer Thresholds in the Investigation of Suspected Pulmonary Embolism: A Retrospective Evaluation in Patients Ag-es 50 and Older Using Administrative Data. Canadian Journal of Emergency Medicine, 20, 725-731. [Google Scholar] [CrossRef] [PubMed]
[12] Barbour, S.J., Greenwald, A., Djurdjev, O., Levin, A., Hladunewich, M.A., Nachman, P.H., Hogan, S.L., Cattran, D.C. and Reich, H.N. (2012) Disease-Specific Risk of Venous Thrombo-embolic Events Is Increased in Idiopathic Glomerulonephritis. Kidney International, 81, 190-195. [Google Scholar] [CrossRef] [PubMed]
[13] Li, S.J., Guo, J.Z., Zuo, K., Zhang, J., Wu, Y., Zhou, C.S., Lu, G.M. and Liu, Z.H. (2012) Thromboembolic Complications in Membranous Nephropathy Patients with Nephrotic Syndrome—A Prospective Study. Thrombosis Research, 130, 501-505. [Google Scholar] [CrossRef] [PubMed]
[14] Righini, M., Van Es, J., Den Exter, P.L., Roy, P.M., Verschuren, F., Ghuysen, A., Rutschmann, O.T., Sanchez, O., Jaffrelot, M., Trinh-Duc, A., et al. (2014) Age-Adjusted D-Dimer Cutoff Levels to Rule out Pulmonary Embolism: The ADJUST-PE Study. Journal of the American Medical Association, 311, 1117-1124. [Google Scholar] [CrossRef] [PubMed]
[15] Hanasaki, K. (2004) Mammalian Phospholipase A2: Phospholipase A2 Receptor. Biological and Pharmaceutical Bulletin, 27, 1165-1167. [Google Scholar] [CrossRef] [PubMed]
[16] Tamaru, S., Mishina, H., Watanabe, Y., Watanabe, K., Fujioka, D., Takahashi, S., Suzuki, K., Nakamura, T., Obata, J.E., Kawabata, K., et al. (2013) Deficiency of Phospholipase A2 Re-ceptor Exacerbates Ovalbumin-Induced Lung Inflammation. The Journal of Immunology, 191, 1021-1028. [Google Scholar] [CrossRef] [PubMed]
[17] Seitz-Polski, B., Dolla, G., Payre, C., Girard, C.A., Polidori, J., Zorzi, K., Birgy-Barelli, E., Jullien, P., Courivaud, C., Krummel, T., et al. (2016) Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy. Journal of the American Society of Nephrology, 27, 1517-1533. [Google Scholar] [CrossRef
[18] Murakami, M., Nakatani, Y., Atsumi, G.I., Inoue, K. and Kudo, I. (2017) Regulatory Functions of Phospholipase A2. Critical Reviews in Immunology, 37, 127-195. [Google Scholar] [CrossRef
[19] Lionaki, S., Derebail, V.K., Hogan, S.L., Barbour, S., Lee, T., Hladunewich, M., Greenwald, A., Hu, Y., Jennette, C.E., Jennette, J.C., et al. (2012) Venous Thromboembolism in Patients with Membranous Nephropathy. Clinical Journal of the American Society of Nephrology, 7, 43-51. [Google Scholar] [CrossRef
[20] Zou, H., Li, Y. and Xu, G. (2019) Management of Anticoagulation and Antiplatelet Therapy in Patients with Primary Membranous Nephropathy. BMC Nephrology, 20, Article No. 442. [Google Scholar] [CrossRef] [PubMed]
[21] Arghiani, M., Zamani, B.H., Nazemian, F., Samadi, S., Afshari-an, M.S., Habibzadeh, M., Eslami, S. and Sabbagh, M.G. (2021) A Cohort Study of Membranous Nephropathy, Primary or Secondary. BMC Nephrology, 22, Article No. 138. [Google Scholar] [CrossRef] [PubMed]